Overview
- 40 inspections across 38 sites are on record.
- 140 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2020-10-28.
At a glance
Inspections
40
Sites
38
Observations
140
Career since
Jan 2016
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Syntec Pharma Corp | 28 Oct 2020 | Human Drugs | On file |
| Niagara Pharmaceuticals, Inc | 7 Feb 2020 | Human Drugs | View 483 → |
| Dalton Chemical Laboratories Inc | 28 Jan 2020 | Human Drugs | On file |
| Time-Cap Laboratories, Inc. | 18 Dec 2019 | Human Drugs | View 483 → |
| A&Z Pharmaceutical Inc | 5 Nov 2019 | Human Drugs |
Sites inspected
Syntec Pharma CorpFarmingdale, United States1 insp.
Niagara Pharmaceuticals, IncDundas, Canada1 insp.
Dalton Chemical Laboratories IncNorth York, Canada1 insp.
Time-Cap Laboratories, Inc.Farmingdale, United States1 insp.
A&Z Pharmaceutical IncHauppauge, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Alice S Tsao4 shared
Meredith P Soehl4 shared
Rachael A Moliver2 shared
Jose O Hernandez2 shared
Vivin George1 shared
Nancy F Scheraga1 shared
Nancy M Espinal1 shared
Russell J Glapion1 shared
Frederick Razzaghi1 shared
Peter M Trunk1 shared
Full investigator report
Get the verbatim findings behind Jay T Wong's 140 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site